biotechnology
Hong Kong CDMO gap delays GenEditBio samples
Hong Kong CDMO gap delays GenEditBio samples
Hetao could fund shared CDMO capacity for first-in-human gene editing samples.
Human microbiome drugs market to be valued at $2.13b by 2031
By end users, the hospitals & clinics segment held the largest market share in 2024.
Asia-Pacific strengthens biotech edge amidst scaling constraints
Government investment powers rapid biotech growth.
Molecular spectroscopy market to be valued at $6.4b by 2034
Key sectors include pharmaceuticals and biotechnology.
GUTolution's AI-powered tech drives personalised solutions for gut health
The biotech’s algorithm aids in customised recommendations by determining disease risks via one’s gut profile.
German pharmaceutical firm plans new APAC bioprocessing plant in South Korea
Merck will use its Asia Pacific Bioprocessing Center for commercial manufacturing for its biotech and pharmaceutical clients.
From accidental to essential — How PairX Bio revolutionises cancer immunotherapies
The startup focuses its efforts on cancer treatment by targeting shared tumour antigens.
Most Read
1. Diffusion to confusion: Solving APAC’s healthcare coordination crisis 2. Singapore develops world-first fluorescent nanosensor to track gut health 3. AI adoption drives clinical decision support market to $10.15b 4. Medical inflation rises to 11.3% as employers face cost squeeze 5. Sankara Eye Hospital-CUHK deal expands paediatric eye care focusResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention